ERBB2 and breast cancer: There are more luminal B‐like subtype and non‐luminal‐like subtypes (i.e., normal‐like, HER2 enriched and basal‐like) among grade III ER+HER2− breast cancer patients than those with grade I/II tumors (Fig. 5A), indicating that high‐grade tumors are heterogeneous.